QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe
Go back to QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe| QUINTILES TRANSNATIONAL HOLDINGS, Inc. (NYSE: Q) | Delayed: 161.19 -14.45 (8.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $175.64 | 52 Week High | $81.45 | |||
| Open | $163.98 | 52 Week Low | $55.01 | |||
| Day High | $167.13 | P/E | 91.07 | |||
| Day Low | $160.08 | EPS | $1.77 | |||
| Volume | 2,404,864 | |||||
